Preferred Label : Stalevo;
Obsolete resource : false;
MeSH note : Levodopa, carbidopa & entacapone (Catechols), intended as improved therapy for Parkinson
Disease;
Is substance : O;
Origin ID : C481098;
UMLS CUI : C1434452;
ATC code(s)
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
- Validated automatic mappings to NTBT
https://www.ema.europa.eu/medicines/human/EPAR/corbilta-previously-levodopacarbidopaentacapone-sandoz
2013
false
United Kingdom
French
English
Stalevo
Stalevo
entacapone
entacapone
drug approval
europe
treatment outcome
levodopa, decarboxylase inhibitor and comt inhibitor
Product containing carbidopa and entacapone and levodopa (medicinal product)
dopamine agents
dopamine agents
administration, oral
drug combinations
antiparkinson agents
antiparkinson agents
parkinson disease
adult
dopa decarboxylase
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
summary of product characteristics
package leaflet
drug evaluation
syndication feed
catechols
catechols
nitriles
nitriles
Catechol O-Methyltransferase Inhibitors
Catechol O-Methyltransferase Inhibitors
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68232927
2012
France
summary of product characteristics
package leaflet
levodopa
carbidopa
Stalevo
tablets
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69044807
2012
France
summary of product characteristics
package leaflet
tablets
levodopa
carbidopa
Stalevo
---
https://www.ema.europa.eu/medicines/human/EPAR/Stalevo
2012
United Kingdom
English
French
syndication feed
drug combinations
parkinson disease
tablets
administration, oral
drug evaluation
treatment outcome
adult
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
drug labeling
drug approval
Stalevo
entacapone
levodopa, decarboxylase inhibitor and comt inhibitor
nitriles
package leaflet
summary of product characteristics
drug evaluation
antiparkinson agents
antiparkinson agents
carbidopa
catechols
levodopa
carbidopa
catechols
levodopa
---
http://www.has-sante.fr/portail/display.jsp?id=c_399946
http://www.has-sante.fr/portail/jcms/c_1281702/stalevo
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-08/stalevo_18072012_avis_ct6580.pdf
2012
false
France
French
Catechol O-Methyltransferase Inhibitors
evaluation of the transparency committee
parkinson disease
antiparkinson agents
dopamine agents
levodopa, decarboxylase inhibitor and comt inhibitor
catechols
nitriles
dopa decarboxylase
insurance, health, reimbursement
levodopa
Stalevo
administration, oral
drug combinations
carbidopa
entacapone
treatment outcome
---
https://www.ema.europa.eu/medicines/human/EPAR/levodopacarbidopaentacapone-orion
2012
false
United Kingdom
French
English
package leaflet
summary of product characteristics
syndication feed
Catechol O-Methyltransferase Inhibitors
Catechol O-Methyltransferase Inhibitors
catechols
catechols
nitriles
nitriles
dopamine agents
dopamine agents
drug evaluation, preclinical
carbidopa
levodopa
Stalevo
entacapone
drug combinations
Stalevo
levodopa
carbidopa
entacapone
levodopa, decarboxylase inhibitor and comt inhibitor
parkinson disease
administration, oral
drug approval
adult
antiparkinson agents
antiparkinson agents
drug interactions
pregnancy
breast feeding
treatment outcome
dopa decarboxylase
---
https://www.cadth.ca/sites/default/files/cdr/complete/cdr_complete_Stalevo_October-2008_f.pdf
2008
Canada
French
drug combinations
carbidopa
catechols
levodopa
parkinson disease
Stalevo
levodopa, decarboxylase inhibitor and comt inhibitor
drug evaluation
---
